Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?

por Bhattacharya, I.S., Kirby, A.M., Bliss, J.M., Coles, C.E.
Publicado 2018

The Cambridge breast intensity modulated radiotherapy trial

por Coles, CE, Wilkinson, JS, Moody, AM, Hoole, ACF, Twyman, N, Burnet, NG
Publicado 2006

Cambridge Breast Intensity Modulated Radiotherapy Trial: dosimetry results for 1,139 patients

por Coles, CE, Wilkinson, JS, Wilson, CB, Burnet, NG, Wishart, GC, Twyman, N, Hoole, ACF, Moody, AM
Publicado 2008

International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic

por Coles, C.E., Aristei, C., Bliss, J., Boersma, L., Brunt, A.M., Chatterjee, S., Hanna, G., Jagsi, R., Kaidar Person, O., Kirby, A., Mjaaland, I., Meattini, I., Luis, A.M., Marta, G.N., Offersen, B., Poortmans, P., Rivera, S.
Publicado 2020

The NeST (neoadjuvant systemic therapy in breast cancer) study – Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of n...

por Irwin, G.W., Bannon, F., Coles, C.E., Copson, E., Cutress, R.I., Dave, R.V., Grayson, M., Holcombe, C., Irshad, S., O'Brien, C., O'Connell, R.L., Palmieri, C., Shaaban, A.M., Sharma, N., Singh, J., Whitehead, I., Potter, S., McIntosh, S.A.
Publicado 2019